VOTIS Subdermal Imaging Technologies
Device for Assessing Foot Patency in People with Peripheral Artery Disease
Startup A Health Tech & Life Sciences Est. 2017
🌐 WebsiteLinkedIn
Total Raised
$8.07M
A
Last Round
$2.27M
6 rounds
Investors
2
2 public
Team
4
11-50 employees
Confidence
99/100
News
7
articles
Patents
1
About
VOTIS Subdermal Imaging Technologies is developing a suite of devices designed to help people with peripheral artery disease (PAD) preserve their feet. The companys PedCheck is used to screen the feet of asymptomatic patients for PAD. If PAD is found, then the PedStage will be used to stage and monitor disease progression and the impact of therapies prescribed by the patients physician. The PedFlo can be used during a revascularization procedure to inform the physician about the level of blood flow in the foot. All three VOTIS devices are safe, noninvasive, and free of ionizing radiation.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareMedical Decision Support
Core Technology
Data StorageCloudPlatforms & InterfacesSoftwareArtificial Intelligence
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
medical-devicesvascularcloud-basedhospitalsscanningdiagnosticsimagingdigital-healthcareemrartificial-intelligencediabetesnon-invasivedeep-learningearly-detectionclinicssoftware-developmentdecision-support
Funding & Events
May 2019
Non-equity $50K
EU Horizon 2020
Jun 2021
A Round $2.5M
Siryo SpA
Apr 2023
Convertible Debt $2.27M
Italian Angels for Growth (Lead)
Non-equity $2.5M
National Institute of Health (NIH)
Non-equity $500K
Wallace H. Coulter Foundation
Non-equity $250K
Partnership for New York City
News (7)
May 2, 2022 · www.prnewswire.com
growth-positive
VOTIS SUBDERMAL IMAGING TECHNOLOGIES, LTD. ANNOUNCES ENROLLMENT OF FIRST HUMAN SUBJECT IN PILOT FEASIBILITY STUDY OF PEDCHECK™ AT HADASSAH MEDICAL CENTER IN JERUSALEM
PartnersCustomers
Nov 14, 2021 · www.israel21c.org
growth-positive
Finding diabetic foot disease before symptoms show up
Customers
Jun 1, 2021 · www.prnewswire.com
growth-positive
VOTIS Subdermal Imaging Technologies Raises US$2.5 Million
Investment
Dec 21, 2020 · www.prnewswire.com
growth-positive
VOTIS Subdermal Imaging Technologies And ii Ventures Announce Plans To Develop Preventative Medicine Devices To Screen For Peripheral Artery Disease In India
PartnersExpand
Oct 12, 2020 · www.prnewswire.com
growth-positive
VOTIS Subdermal Imaging Technologies Licenses Imaging Technology From Columbia University
Customers
Nov 14, 2018 · nocamels.com
growth-positive
6 Israeli Companies At The Forefront Of Diabetes Care, Prevention, And Treatment
Customers
Apr 24, 2018 · globenewswire.com
growth-positive
Finalists Announced for 2018 Diabetes Innovation Challenge
Partners
Details
Product Stage
Clinical Trial
Employees
11-50
Exact Count
14
District
Jerusalem District
Founded
2017
Registrar
515675379
Crunchbase
votis-subdermal-imaging-technologies
Locations
Dostai Street 3, Jerusalem, Israel
Links
Website
www.votis.net
LinkedIn
Profile
Facebook
Page
Admin
Last Update
Sep 21, 2024
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
markets
Team (4)
Brian Glenville
Executive Chairman
Merrill Weber
Co-founder & CEO
Founder
Bezalel Jakobowitz
CFO
Andreas Hielscher
Chief Technology Advisor
Internal
Created by
Hilla Gorokhovsky (hilla.gorokhovsky@sncentral.org)
Created
2018-02-26T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Finder · VOTIS Subdermal Imaging Technologies · 2026